An estimate of cancer deaths and incidence for the years 1997 and 2002, taking account of current trends and population projections for Northern Ireland is presented below. These numbers will be of value to those planning services and, in particular, for those implementing the report "Cancer Services -Investing for the Future".' Cancer deaths are expected to rise by almost 13 % to 4056 by the year 2002. Marked rises are expected in the number of deaths from cancer of the lung, oesophagus, kidney, bladder and prostate with smaller rises in deaths from breast and pancreatic cancer. The fall in stomach cancer is expected to continue as is the trend of lower deaths from cervical cancer. Deaths from cancer of the colon and rectum are expected to remain static. Estimates of cancer incidence currently and for the years 1997 and 2002 are also included. The impact of tobacco use by the population, which poses a current and future serious threat to public health is highlighted.
. The number of lung cancer deaths will rise by 30% to 1,033. The fall in deaths in men under 65 from 160 to 129 will be offset by an increase in deaths among older men and women (see Table I ). The number of lung cancers diagnosed is expected to rise from current estimates of 953 to 1,239 by 2002 (see Table II ). The fall in levels among younger men will again be offset by the rise in levels among older men and both older and younger women. Deaths from cancer of the oesophagus are expected to rise 35% by 2002 to 157. The biggest increases will be in younger men while in women the rise will be mainly in those over 65, giving rise to an expected 58 female oesophageal cancer deaths. Table I ).
Cancer of the stomach should continue to fall so that by 2002 there should be 104 male cancer deaths and 59 stomach cancer deaths in women (see Figure 2 and Table I ). The numbers of stomach cancers diagnosed is also expected to fall to 212 by 2002 (see Table II ). The number of deaths from cancers of the colon and rectum are expected to remain unchanged over this period. A fall in deaths among older women and, to a lesser extent amongst younger women is predicted to be offset by the rise in deaths of older men (see Table I ). Deaths Figure 3 and Table III) . 56  39  35  31  90  89  88  2  Total  69  73  75  50  45  40  119  117  115  3   Pancreas  157  <65  22  20  18  19  19  19  40  39  37   1  >65  53  57  58  65  68  69  118  124  127  0  Total  75  76  77  84  87  88  158  163  165  1   Lung   162  <65  160  144  129  71  83  91  232  227  220  27  >65  391  446  490  171  250  323  563  697  813  40   Total  552  590  619  243  333  413  794  923  1033  65   Bladder  188  <65  12  12  12  40  42  42  52  54  54  0  >65  51  57  61  47  49  50  98  1906  111  5  Total  62  69  73  88  91  92  150  160  165  5   Kidney   189  <65  16  17  17  1  2  2  17  18  19  0  >65  26  32  39  10  13  16  36  45  54  5  Total  42  49  55  11  15  18  53  64  73  5   All Cancers  <65  536  536  527  527  543  547  1063  1079  1074  11   >65  1320  1480  1602  1212  1319  1380  2532  2799  2982  64   Total  1856 2017 2129  1738  1861  1927 3595 3878 4056  75 Deaths from cancer of the kidney and renal parenchyma (ICD 189) are expected to rise by 39% from 53 in 1991 to 73 in 2002. Most of this increase will be accounted for by a continued rise in deaths in older men (see Figure 4 and Table I ). It is calculated there will be 132 new cases of kidney cancer diagnosed in the year 2002 (see Table II ). Deaths from cancer of the prostate are expected to rise by 20% to 219 by the year 2002. This increase based on current trends (see Figure 5 ) will be totally in men over 65. The predicted number of new cases diagnosed is 416 for the year 2002 (see Table III ).
Deaths from bladder cancer are predicted to rise by 10% to 165 in the same period. This increase will be largely in men over 65. It is expected there will be 496 new cases of this cancer diagnosed by the year 2002. respectively. An important premise is that the incidence to mortality ratio should remain constant. Only time will tell if this was valid. It is possible that risk factor change may affect both incidence and survivorship and that new therapies and/or better organisation of cancer services may reduce mortality rates independently of incidence rate change. Also, the calculations cannot take account 10 The trend of rising deaths from lung cancer among young women more than offsets the health gain achieved by falling tobacco use by younger men. This is likely to continue. Currently 27% of men and 33% of women aged 16-34 are smokers. This identifies an area for urgent attention to protect the health of the population in N. Ireland and achieve the targets of the N. Ireland Regional Strategy for reduction in lung cancers." The target for 2010 is to reduce the death rate from lung cancer by at least 30% in men under 75 and 15% in women under 75. The need for accurate incidence information on cancer, a major disease group which accounts for 23% of deaths, over 20,000 hospital admissions and an unmeasured amount of health service resources is again highlighted. We look forward to the time when the N. Ireland Cancer Registry is regularly producing timely accurate information on cancer in N. Ireland for the purposes of research, education and planning of services. In the meanwhile these predictions should assist the N. Ireland Cancer Working Group in making decisions on the future of cancer services and enhance the precision of data available to those planning cancer services.
